Comment on “Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer” by Lan WG et al.

被引:0
|
作者
G. Yavas
C. Yavas
S. Akyurek
机构
[1] Selcuk University,Department of Radiation Oncology
[2] Ankara University,Department of Radiation Oncology
来源
关键词
Serum HE4; Human Epididymis Protein 4 (HE4); Concurrent Chemoradiotherapy; Shorter RFS; Smoking Index;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:801 / 802
页数:1
相关论文
共 50 条
  • [41] Evaluation of standard chemo-radiotherapy in older patients with locally advanced non-small cell lung cancer (NSCLC) enrolled in a multicenter randomized phase II study
    Goetz, G. Des
    Bouillet, T.
    Etessami, R.
    Diana, C.
    Labrune, S.
    Gervais, R.
    Virally, J.
    Hamond, K.
    Spano, J. -P.
    Sebbane, G.
    Valeyre, D.
    Morere, J. -F.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 64 : S38 - S38
  • [42] A Multicenter Randomized Phase III Trial to Compare Weekly Usage with Triweekly Usage of Docetaxel and Cisplatin in Concurrent Chemo-radiotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer.
    Jiang, L.
    Zhu, G.
    Wang, J.
    Shi, A.
    Yu, R.
    Ge, H.
    Li, J.
    Li, X.
    Yan, S.
    Zhang, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E511 - E512
  • [43] PHASE II TRIAL: CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY WITH NITROGLYCERIN IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS
    De La Mata, Dolores
    Blake-Cerda, Monika
    Zamora, Jesus
    Pena, Omar
    Flores-Estrada, Diana
    Turcott, Jenny
    Arrieta, Oscar
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S133 - S134
  • [44] Phase I Study of Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer
    Li, Bao-Sheng
    Gong, He-Yi
    Huang, Wei
    Yi, Yan
    Yu, Jin-Mimg
    Wang, Zhong-Tang
    Zhang, Zi-Cheng
    Sun, Hong-Fu
    Li, Hong-Sheng
    Wang, Li-Ying
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (02): : 115 - 119
  • [45] Phase II trial: Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer patients
    De la Mata, Dolores
    Blake, Monika
    Zamora Moreno, Jesus
    Pena, Omar
    Flores-Estrada, Diana
    Turcott, Jenny
    Arrieta, Oscar
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Concurrent versus sequential chemotherapy with hypofractionated radiotherapy in patients with inoperable locally advanced non-small cell lung cancer
    Guo, Wei
    Gu, Xiaobin
    Gao, Xianshu
    Ma, Mingwei
    Cui, Ming
    Xie, Mu
    Bai, Yun
    Peng, Chuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (07): : 10443 - 10452
  • [47] Concurrent biweekly gemcitabine plus cisplatin chemotherapy and radiotherapy in patients with locally advanced non-small cell lung cancer
    Jung, M
    Kim, H
    Oak, C
    Jang, T
    Jeon, Y
    Jung, T
    LUNG CANCER, 2005, 49 : S170 - S170
  • [48] Phase I Study of Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients with Locally Advanced Non-small Cell Lung Cancer
    Li, B.
    Yi, Y.
    Wang, Z.
    Sun, H.
    Gong, H.
    Zhang, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S464 - S465
  • [49] IMPACT OF PRETRETMENT LEUKOCYTOSIS ON PROGNOSIS IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY
    Topkan, Erkan
    Parlak, Cem
    Pehlivan, Berrin
    Ozyilkan, Ozgur
    Selek, Ugur
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S556 - S556
  • [50] IMPACT OF PRETRETMENT LEUKOCYTOSIS ON PROGNOSIS IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY
    Topkan, Erkan
    Parlak, Cem
    Guler, Ozan C.
    Pehlivan, Berrin
    Selek, Ugur
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S412 - S412